MTDR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Matador Resources Co (MTDR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows mixed signals with no significant positive catalysts, and the financial performance has weakened in the latest quarter. Analysts have recently downgraded the stock or reduced price targets, and the technical indicators suggest a neutral trend. Given the investor's preference for long-term growth and the lack of strong buy signals, holding off on this investment is recommended.
The MACD histogram is positive at 0.301 but contracting, indicating a weakening bullish momentum. RSI is neutral at 54.641, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 45.949, with resistance at 48.15 and support at 43.749. Overall, the technical indicators suggest a neutral trend.
No significant positive catalysts identified. The company has a strong presence in the Delaware Basin, which provides a unique growth narrative according to some analysts.
Recent analyst downgrades and reduced price targets. Weak financial performance in Q3 2025 with a significant drop in net income (-28.97%) and EPS (-28.64%). Gross margin also declined by 21.19%. No recent news or congress trading data to support positive sentiment. Stock trend analysis suggests a potential short-term decline.
In Q3 2025, revenue increased by 6.39% YoY to $915.1M, but net income dropped by 28.97% YoY to $176.4M. EPS fell by 28.64% YoY to 1.42, and gross margin declined by 21.19% to 35.08%. This indicates weakening profitability despite revenue growth.
Recent analyst activity shows mixed to negative sentiment. Wells Fargo downgraded the stock to Equal Weight with a price target of $47, citing balanced risk/reward and higher capital intensity. Morgan Stanley reduced its price target to $52, and JPMorgan lowered its target to $52 while maintaining an Overweight rating. BofA and Mizuho remain positive but cautious, with price targets of $52 and $70, respectively. Overall, analysts are cautious about the stock's near-term prospects.
